Context: Rizatriptan is a selective 5-HT 1B/1D receptor agonist for the acute treatment of migraine. It is available in a unique wafer formulation that dissolves rapidly in the mouth and can be ...
The study conformed to Good Clinical Research Practice. This outpatient study compared the clinical profiles of rizatriptan 10-mg and 5-mg wafers to standard care for the acute treatment of migraine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback